FDA Inspection 653960 — CMP Pharma Inc
The FDA completed an inspection of CMP Pharma Inc on March 17, 2010 in Farmville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 17, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Farmville, NC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)